SPY313.78-3.27 -1.03%
DIA259.04-3.96 -1.51%
IXIC10,343.89-89.76 -0.86%

Ladenburg Thalmann Initiates Coverage On Windtree Therapeutics with Buy Rating, Announces Price Target of $12.25

Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Windtree Therapeutics (NASDAQ:WINT) with a Buy rating and announces Price Target of $12.25.

Benzinga · -
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Windtree Therapeutics (NASDAQ: WINT) with a Buy rating and announces Price Target of $12.25.